Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Prasad

Showing results (41-50 of 1,315) with videos related to

Pageof 132
Sort By:
Blood Cancer Journal|November 4, 2017
The availability of jobs in the biopharmaceutical industry is 45-fold greater for hematology oncology than medical specialtiesV Kaestner, V Prasad
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2019
Making adjuvant therapy decisions with uncertain dataB Gyawali, V Prasad
The Journal of Dairy Research|August 1, 1997
Effect of yogurt and bifidus yogurt fortified with skim milk powder, condensed whey and lactose-hydrolysed condensed whey on serum cholesterol and triacylglycerol levels in ratsA Beena, V Prasad
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2018
When is crossover desirable in cancer drug trials and when is it problematic?A Haslam, V Prasad
Bulletin of the Indian Institute of History of Medicine (Hyderabad)|March 6, 2007
Medico - historical study of "Visŭcikă" (Cholera)P V V Prasad
The International Journal of Neuroscience|October 1, 1992
Hemispheric priming: effect of response mode on a position replication taskJ Cochran, V Prasad
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2023
Costs per event averted in the neoadjuvant and adjuvant settings of early triple-negative breast cancerT Olivier, V Prasad
Blood Cancer Journal|October 11, 2017
Job postings for biopharmaceutical industry in medical journals is 45-fold greater for hematology oncology than medical specialtiesV Kaestner, V Prasad
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
When are randomized controlled trials needed to assess novel anticancer drugs? An illustration based on the development of selpercatinib, a RET inhibitorJ Gill, V Prasad
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 11, 2020
The FDA approval of pembrolizumab for patients with TMB >10 mut/Mb: was it a wise decision? NoV Prasad, A Addeo
Pageof 132

Showing results (41-50 of 1,315) with videos related to

Sort By:
Pageof 132
Blood Cancer Journal|November 4, 2017
The availability of jobs in the biopharmaceutical industry is 45-fold greater for hematology oncology than medical specialtiesV Kaestner, V Prasad
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 5, 2019
Making adjuvant therapy decisions with uncertain dataB Gyawali, V Prasad
The Journal of Dairy Research|August 1, 1997
Effect of yogurt and bifidus yogurt fortified with skim milk powder, condensed whey and lactose-hydrolysed condensed whey on serum cholesterol and triacylglycerol levels in ratsA Beena, V Prasad
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2018
When is crossover desirable in cancer drug trials and when is it problematic?A Haslam, V Prasad
Bulletin of the Indian Institute of History of Medicine (Hyderabad)|March 6, 2007
Medico - historical study of "Visŭcikă" (Cholera)P V V Prasad
The International Journal of Neuroscience|October 1, 1992
Hemispheric priming: effect of response mode on a position replication taskJ Cochran, V Prasad
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 9, 2023
Costs per event averted in the neoadjuvant and adjuvant settings of early triple-negative breast cancerT Olivier, V Prasad
Blood Cancer Journal|October 11, 2017
Job postings for biopharmaceutical industry in medical journals is 45-fold greater for hematology oncology than medical specialtiesV Kaestner, V Prasad
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 19, 2020
When are randomized controlled trials needed to assess novel anticancer drugs? An illustration based on the development of selpercatinib, a RET inhibitorJ Gill, V Prasad
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 11, 2020
The FDA approval of pembrolizumab for patients with TMB >10 mut/Mb: was it a wise decision? NoV Prasad, A Addeo
Pageof 132